Rare Diseases & Orphan drugs

Rare diseases are life-threatening or chronically debilitating conditions, affecting no more than 5 in 10,000 persons in the European Community according to the Regulation (EC) N. 141/2000 of the European Parliament and of the Council. It is estimated that between 6000 to 8000 distinct rare diseases affect up to 6% of the total EU population. Therefore, these conditions can be considered rare if taken individually but they affect a significant proportion of the European population when considered as a single group. Several initiatives have been taken at international, European and national level to tackle public health as well as research issues related to diagnosis, prevention, treatment and surveillance of these diseases. An Orphan drug can be defined as the one that is used to treat an orphan disease. An orphan disease in USA is defined as the one that affects fewer than 200000 individuals, but in Japan the number is 50,000 and in Australia is 2000. In past 20 years efforts have been made to encourage companies to develop orphan drugs. The Orphan Drug Act in the USA (1983) was succeeded by similar legislation in Japan (1985), Australia (1997), and the European Community (2000). The encouragement takes three forms: tax credits and research aids, simplification of marketing authorization procedures, and extended market exclusively. 

  • Craniofacial Morphogenesis
  • Diverse Immunotherapy Approaches
  • T cell immunotherapy
  • Gene, stem cell and future therapies for orphan diseases
  • Rare Diseases and Regenerative Medicine

Related Conference of Rare Diseases & Orphan drugs

March 5-7, 2018

20th Global Congress on Biotechnology

Park Inn by Radisson Hotel London, UK
May 09-10, 2018

11th World Congress on Cell & Tissue Science

Tokyo, Japan
May 14-15, 2018

World Congress on Cell and Structural Biology

Osaka Japan
May 21-23, 2018

6th International Conference on Integrative Biology

Barcelona, Spain
June 04-06, 2018

12th Annual Conference on Stem Cell and Regenerative Medicine

Prague, Czech Republic
July 2-3, 2018

4th International Conference on Bioscience

Vienna, Austria
July 23-24, 2018

Annual Biotechnology Congress

Vancouver, British Columbia, Canada
September 3-4, 2018

World Congress on Stem Cell Biology and Biobanking

Tokyo, Japan
SEPTEMBER 24-25, 2018

5th World Congress on HUMAN GENETICS

BERLIN, GERMANY
September 17-18, 2018

International Podiatry Conference

Dubai, UAE
September 19 - 20, 2018

2nd Annual summit on Cell Signaling and Cancer Therapy

Philadelphia, Pennsylvania, USA
September 19 - 20, 2018

2nd Annual summit on Cell Metabolism and Cytopathology

Philadelphia, Pennsylvania, USA
September 19th -20th, 2018

World Congress on Synthetic Biology and Advanced Biomaterials

Tokyo,Japan
September 20-21,2018

6th Annual Congress on Biology and Medicine of Molecules

Kuala Lumpur, Malaysia
September 20-21, 2018

Tissue Repair and Regeneration Congress

Dubai, UAE
September 21-22, 2018

11th International Conference on Genomics and Pharmacogenomics

Philadelphia, Pennsylvania, USA
September 21-22, 2018

5th International Conference on Human Genetics and Genetic Disorders

Philadelphia, Pennsylvania, USA
October 24-25, 2018

24th Biotechnology Congress: Research & Innovations

Boston, USA
November 2-3, 2018

International Congress & Expo on Genomics and Bioinformatics

Columbus, Ohio, USA
November 9-10, 2018

2nd Annual Summit on Cell Therapy and Stem Cell Research

Atlanta, Georgia, USA
November 9-10, 2018

2nd Annual Summit on Cell Therapy and Regenerative Medicine

Atlanta, Georgia, USA
Dec 03-04, 2018

3rd World Biotechnology Congress


(10 Plenary Forums - 1Event)
Sao Paulo, Brazil

Rare Diseases & Orphan drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in